Si Li

Director, R&D US at TCRCure Biopharma

Si Li is an Director of R&D US at TCRCure Biopharma. Si has over five years of experience in biomedical engineering and cancer research. Prior to joining TCRCure, Si worked as a Graduate Research Assistant at USC Viterbi School of Engineering, where they engineered CAR-T cells to constitutively secrete anti-human PD-1 scFv and evaluated its antitumor efficacy. Si has also published several papers in renowned journals such as Clin Cancer Res and Mol Ther Oncolytics.

Si Li received a Bachelor of Science in Economics from Peking University and a Bachelor of Science in Basic Medical Sciences from Peking University. Si then went on to receive a Master of Science in Regulatory Science from the University of Southern California. Si Li is currently pursuing a Doctor of Philosophy in Pharmaceutical Sciences with a focus in Cancer Immunotherapy from the University of Southern California.

Si Li reports to Qi-Jing Li, Co-Founder. Si Li works with Ann Wong - HR & Admin. Director, Rui Chen - R&D Director & PI Head, and Dawn Sheng - Head, Legal & Compliance.

Links

Timeline

  • Director, R&D US

    July, 2022 - present

  • Associate Director, R&D US

View in org chart